Leverette 21 (Ethinylestradiol, Levonorgestrel)

Leverette 21, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent unintended pregnancy and manage related menstrual conditions.

• Contraception: prevention of unintended pregnancy in women of reproductive age.
• Menstrual cycle regulation: reduction of irregular bleeding and stabilization of cycle length.
• Acne management: improvement of moderate acne associated with androgen excess.

• Ethinylestradiol binds to estrogen receptors, delivering negative feedback to the hypothalamic‑pituitary axis, while levonorgestrel activates progesterone receptors, suppressing the luteinizing hormone surge. The combined action inhibits ovulation, thickens cervical mucus, and induces endometrial changes that together prevent fertilization and implantation. Additionally, the progestogenic component reduces endometrial proliferation, contributing to contraceptive efficacy.

Leverette 21 may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Breast tenderness: discomfort or swelling of the breasts.
• Headache: transient cranial pain.
• Spotting or breakthrough bleeding: irregular light bleeding.
• Weight gain: modest increase in body weight.
• Mood changes: irritability or emotional fluctuations.

Serious or Rare Side Effects

• Venous thromboembolism: deep vein thrombosis or pulmonary embolism.
• Stroke: cerebrovascular accident, especially in high‑risk individuals.
• Myocardial infarction: heart attack due to arterial blockage.
• Severe hypertension: sudden rise in blood pressure.
• Allergic reaction: rash, swelling, or anaphylaxis.
• Liver dysfunction: jaundice or abnormal liver enzymes.

Before prescribing Leverette 21, clinicians should consider several safety precautions to minimize risk.

• Pregnancy contraindication: must not be used during pregnancy (Category X).
• Smoking restriction: avoid in women over 35 who smoke.
• Thromboembolic history: contraindicated in patients with past venous or arterial clotting events.
• Hypertension: caution in uncontrolled high blood pressure.
• Liver disease: avoid in active liver disease or severe hepatic impairment.
• Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and light.

Leverette 21 can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): reduce contraceptive efficacy.
• Rifampicin and other rifamycins: markedly decrease hormone levels.
• Protease inhibitors (e.g., ritonavir): increase risk of hormonal side effects.
• St John’s wort: may lower contraceptive effectiveness.
• Certain antiretrovirals (e.g., efavirenz): diminish hormone exposure.

Moderate Interactions (Monitor Closely)

• Antifungal agents (e.g., ketoconazole): may increase hormone concentrations.
• SSRIs (e.g., fluoxetine): possible alteration of bleeding patterns.
• Antihypertensives (e.g., beta‑blockers): monitor blood pressure changes.
• Diuretics: may affect electrolyte balance and blood pressure.
• Herbal supplements (e.g., ginseng): observe for reduced contraceptive reliability.